Podiatrists in Henderson, KY Accepting Medicare

4 Podiatrists found. Showing 1 - 4

Dr. Peter James Doll, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 323 8th St, Henderson, KY 42420 Phone: 270-827-2548    Fax: 270-827-4557

Edward Anderson, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 411 Letcher St, Henderson, KY 42420 Phone: 270-830-6522

Joseph H Wilson, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 1300 Merritt Dr, Henderson, KY 42420 Phone: 270-827-0064    Fax: 270-826-3338

Tri-state Podiatric Medical Services Psc Podiatrist Medicare: Medicare Enrolled Practice Location: 411 Letcher St, Henderson, KY 42420 Phone: 270-830-6522

News Archive

Gates Foundation plans to invest in biotech companies to improve global access to treatments, vaccines for infectious diseases

The Bill & Melinda Gates Foundation "plans to take equity stakes in up to a dozen biotech companies this year, signaling a shift towards a 'venture capital' approach at the world's biggest philanthropic organization" and "marking a further move away from its traditional approach of grant-giving and towards a more business-oriented way to support the development of treatments and vaccines for infectious diseases affecting the world's poor," the Financial Times reports.

New strategy for fighting infection targets patient's cells rather than invading pathogens

As more reports appear of a grim "post-antibiotic era" ushered in by the rise of drug-resistant bacteria, a new strategy for fighting infection is emerging that targets a patient's cells rather than those of the invading pathogens.

Organ transplant patients have higher risk for skin cancer

While anyone can develop skin cancer, regardless of age, race or gender, certain groups of people have a higher risk of getting the disease than others.

Drugs that target DNA in later-stage cancers could be effective in treating breast tumors

Breast cancers that arise sporadically, rather than through inheritance of certain genes, likely start with defects of DNA repair mechanisms that allow environmentally triggered mutations to accumulate, according to researchers at the University of Pittsburgh School of Medicine, Magee-Womens Hospital of UPMC and the University of Pittsburgh Cancer Institute.

TransPharma's Phase 2A trial of ViaDerm-hPTH(1-34) for treating severe osteoporosis is successful

TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of the Phase 2A trial of ViaDerm-hPTH(1-34) which is being developed for the treatment of severe osteoporosis.

Read more Medical News

› Verified 5 days ago